Skip to main content

Search Results: keywords:"biologics patent dispute"

  • S. 1041, also known as the “Affordable Prescriptions for Patients Act,” seeks to change patent laws to address how patents for biological products are handled when there's an accusation of patent infringement. The bill specifically limits the number of patents a reference...

    Simple Explanation

    The Affordable Prescriptions for Patients Act is a new rule that tries to make medicine cheaper by changing how many patents a company can use when they argue about who invented a medicine made from living things. It also sets limits to help keep the fight fair so everyone can get the medicine they need.